Oroxylin A

Oroxylin A is a lipid of Polyketides (PK) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 747 references associated with Oroxylin A in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Oroxylin A

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Oroxylin A

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Seizures D012640 87 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Per page 10 20 | Total 12

NCBI Entrez Crosslinks

All references with Oroxylin A

Download all related citations
Per page 10 20 50 100 | Total 124
Authors Title Published Journal PubMed Link
Fong SY et al. Development of a SPE-LC/MS/MS method for simultaneous quantification of baicalein, wogonin, oroxylin A and their glucuronides baicalin, wogonoside and oroxyloside in rats and its application to brain uptake and plasma pharmacokinetic studies. 2014 J Pharm Biomed Anal pmid:24803030
Fong SY and Zuo Z Species difference in the inhibitory potentials of non-steroidal anti-inflammatory drugs on the hepatic sulfation and glucuronidation of bioactive flavonoids: differential observations among common inhibition parameters. 2014 Xenobiotica pmid:24168065
Kim DH et al. Oroxylin A enhances memory consolidation through the brain-derived neurotrophic factor in mice. 2014 Brain Res. Bull. pmid:25218897
Hui H et al. Oroxylin A inhibits ATRA-induced IL-6 expression involved in retinoic acid syndrome by down-regulating CHOP. 2014 Gene pmid:25192658
Cheng Y et al. Oroxylin A inhibits hypoxia-induced invasion and migration of MCF-7 cells by suppressing the Notch pathway. 2014 Anticancer Drugs pmid:24637576
Ku SK et al. Inhibitory effects of oroxylin A on endothelial protein C receptor shedding in vitro and in vivo. 2014 BMB Rep pmid:24286327
Zhu L et al. Oroxylin A reverses P-glycoprotein-mediated multidrug resistance of MCF7/ADR cells by G2/M arrest. 2013 Toxicol. Lett. pmid:23470866
Wei L et al. Oroxylin A sensitizes non-small cell lung cancer cells to anoikis via glucose-deprivation-like mechanisms: c-Src and hexokinase II. 2013 Biochim. Biophys. Acta pmid:23500080
Yang X et al. Oroxylin A inhibits colitis-associated carcinogenesis through modulating the IL-6/STAT3 signaling pathway. 2013 Inflamm. Bowel Dis. pmid:23823704
Wei L et al. Oroxylin A induces dissociation of hexokinase II from the mitochondria and inhibits glycolysis by SIRT3-mediated deacetylation of cyclophilin D in breast carcinoma. 2013 Cell Death Dis pmid:23598413
Dong J et al. Oroxylin A inhibits hemolysis via hindering the self-assembly of α-hemolysin heptameric transmembrane pore. 2013 PLoS Comput. Biol. pmid:23349625
Yoon SY et al. Oroxylin A improves attention deficit hyperactivity disorder-like behaviors in the spontaneously hypertensive rat and inhibits reuptake of dopamine in vitro. 2013 Arch. Pharm. Res. pmid:23371806
Liu X et al. The ameliorating effects of 5,7-dihydroxy-6-methoxy-2(4-phenoxyphenyl)-4H-chromene-4-one, an oroxylin A derivative, against memory impairment and sensorimotor gating deficit in mice. 2013 Arch. Pharm. Res. pmid:23543630
dela Peña IC et al. 5,7-Dihydroxy-6-methoxy-4'-phenoxyflavone, a derivative of oroxylin A improves attention-deficit/hyperactivity disorder (ADHD)-like behaviors in spontaneously hypertensive rats. 2013 Eur. J. Pharmacol. pmid:23707903
Wang H et al. An estrogen receptor dependent mechanism of Oroxylin A in the repression of inflammatory response. 2013 PLoS ONE pmid:23922737
Zhu R et al. Oroxylin A accelerates liver regeneration in CClâ‚„-induced acute liver injury mice. 2013 PLoS ONE pmid:23951204
Dai Q et al. Two p53-related metabolic regulators, TIGAR and SCO2, contribute to oroxylin A-mediated glucose metabolism in human hepatoma HepG2 cells. 2013 Int. J. Biochem. Cell Biol. pmid:23612020
Qiu J et al. Molecular modeling reveals the novel inhibition mechanism and binding mode of three natural compounds to staphylococcal α-hemolysin. 2013 PLoS ONE pmid:24312202
Kim DH et al. 4'-bromo-5,6,7-trimethoxyflavone represses lipopolysaccharide-induced iNOS and COX-2 expressions by suppressing the NF-κB signaling pathway in RAW 264.7 macrophages. 2012 Bioorg. Med. Chem. Lett. pmid:22101131
Yang HY et al. Oroxylin A reverses multi-drug resistance of human hepatoma BEL7402/5-FU cells via downregulation of P-glycoprotein expression by inhibiting NF-κB signaling pathway. 2012 Mol. Carcinog. pmid:21557331
Zou M et al. Beclin 1-mediated autophagy in hepatocellular carcinoma cells: implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling. 2012 Cell. Signal. pmid:22560876
Hu R et al. The role of Nrf2 and apoptotic signaling pathways in oroxylin A-mediated responses in HCT-116 colorectal adenocarcinoma cells and xenograft tumors. 2012 Anticancer Drugs pmid:22526619
Ha J et al. Oroxylin A improves the sensitivity of HT-29 human colon cancer cells to 5-FU through modulation of the COX-2 signaling pathway. 2012 Biochem. Cell Biol. pmid:22607196
Xu M et al. Activation of the unfolded protein response contributed to the selective cytotoxicity of oroxylin A in human hepatocellular carcinoma HepG2 cells. 2012 Toxicol. Lett. pmid:22609744
Lu Z et al. Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway. 2012 Toxicol. Lett. pmid:22245252
Zhu B et al. Oroxylin A reverses CAM-DR of HepG2 cells by suppressing Integrinβ1 and its related pathway. 2012 Toxicol. Appl. Pharmacol. pmid:22310179
Fu W et al. Synthesis and biological evaluation of 7-O-modified oroxylin A derivatives. 2012 Bioorg. Med. Chem. Lett. pmid:22196122
Tong L et al. Simultaneous determination of baicalin, wogonoside, baicalein, wogonin, oroxylin A and chrysin of Radix scutellariae extract in rat plasma by liquid chromatography tandem mass spectrometry. 2012 J Pharm Biomed Anal pmid:22703838
Pham TA et al. Oroxylin A analogs exhibited strong inhibitory activities against iNOS-mediated nitric oxide (NO) production. 2012 Bioorg. Med. Chem. Lett. pmid:22366656
Wang H et al. [Vasodilator effect of oroxylin A on thoracic aorta isolated from rats]. 2012 Zhong Xi Yi Jie He Xue Bao pmid:22883404
Song X et al. Oroxylin A, a classical natural product, shows a novel inhibitory effect on angiogenesis induced by lipopolysaccharide. 2012 Pharmacol Rep pmid:23238475
Liu PW et al. STAT1 mediates oroxylin a inhibition of iNOS and pro-inflammatory cytokines expression in microglial BV-2 cells. 2012 PLoS ONE pmid:23236370
Guo H et al. [Preparation of flavonoid reference standards from Scutellariae Radix under the guidance of high performance liquid chromatography-mass spectrometry analysis]. 2012 Se Pu pmid:23189664
Tseng TL et al. Oroxylin-A rescues LPS-induced acute lung injury via regulation of NF-κB signaling pathway in rodents. 2012 PLoS ONE pmid:23071799
Lu QY et al. Detection of baicalin metabolites baicalein and oroxylin-a in mouse pancreas and pancreatic xenografts. 2012 Pancreas pmid:22158070
Li C et al. Comparison of intestinal absorption and disposition of structurally similar bioactive flavones in Radix Scutellariae. 2012 AAPS J pmid:22167378
Jeon SJ et al. Oroxylin A increases BDNF production by activation of MAPK-CREB pathway in rat primary cortical neuronal culture. 2011 Neurosci. Res. pmid:21145362
Li C et al. Identification and quantification of baicalein, wogonin, oroxylin A and their major glucuronide conjugated metabolites in rat plasma after oral administration of Radix scutellariae product. 2011 J Pharm Biomed Anal pmid:21051171
Lee S et al. Oroxylin A, a flavonoid, stimulates adult neurogenesis in the hippocampal dentate gyrus region of mice. 2010 Neurochem. Res. pmid:20680459
Zhao L et al. Synergistic effect of 5-fluorouracil and the flavanoid oroxylin A on HepG2 human hepatocellular carcinoma and on H22 transplanted mice. 2010 Cancer Chemother. Pharmacol. pmid:19585117
Gao Y et al. Oroxylin A inhibits angiogenesis through blocking vascular endothelial growth factor-induced KDR/Flk-1 phosphorylation. 2010 J. Cancer Res. Clin. Oncol. pmid:19888602
Zhou Q et al. Use of isoform-specific UGT metabolism to determine and describe rates and profiles of glucuronidation of wogonin and oroxylin A by human liver and intestinal microsomes. 2010 Pharm. Res. pmid:20411407
Marques MR et al. Flavonoids with prolyl oligopeptidase inhibitory activity isolated from Scutellaria racemosa Pers. 2010 Fitoterapia pmid:20117183
Kumar GS et al. Synthesis and biological evaluation of novel benzyl-substituted flavones as free radical (DPPH) scavengers and α-glucosidase inhibitors. 2010 J Asian Nat Prod Res pmid:21061220
Trinh HT et al. Anti-pruritic effect of baicalin and its metabolites, baicalein and oroxylin A, in mice. 2010 Acta Pharmacol. Sin. pmid:20453872
Li HN et al. Apoptosis induction of oroxylin A in human cervical cancer HeLa cell line in vitro and in vivo. 2009 Toxicology pmid:19135124
Sun Y et al. Oroxylin A suppresses invasion through down-regulating the expression of matrix metalloproteinase-2/9 in MDA-MB-435 human breast cancer cells. 2009 Eur. J. Pharmacol. pmid:19100732
Liu W et al. MAC-related mitochondrial pathway in oroxylin-A-induced apoptosis in human hepatocellular carcinoma HepG2 cells. 2009 Cancer Lett. pmid:19473757
Mu R et al. Involvement of p53 in oroxylin A-induced apoptosis in cancer cells. 2009 Mol. Carcinog. pmid:19626645
Zhou XQ et al. [Flavonoids from Scutellaria baicalensis and their bioactivities]. 2009 Beijing Da Xue Xue Bao pmid:19829679